ConductScience.org, home
T24
API referenceFor AI assistants

Cell line · CVCL_0554

Papers144

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

1 to 20 of 144

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
Capsaicin enhances chemosensitivity and mitigates MMP11-driven aggressiveness in human bladder cancer.Cancer Cell Int2026Its Methods give the RRID and name the linePubMed
SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis.Transl Androl Urol2026Its Methods give the RRID and name the linePubMed
Isocyanate-Modified Melatplatin(IV) Enhances Antitumor Efficacy via TCF4/COL6A3-Mediated Extracellular Matrix Remodeling and cGAS-STING Pathway Activation in Bladder Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
HRAS promotes mutant NRAS-driven transformation with codon and allele specificity.Sci Signal2026Its Methods give the RRID and name the linePubMed
Pentachlorophenol enhances bladder cancer cell invasion through altered protein stability.iScience2026Its Methods give the RRID and name the linePubMed
Enfortumab vedotin induces immunogenic cell death and shows enhanced preclinical antitumor activity when combined with a PD-1 inhibitor.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
Rapid normal fibroblast-tumor crosstalk promotes cancer-associated fibroblast-like activation and attenuates mitomycin C cytotoxicity in bladder cancer.J Cell Commun Signal2026Its Methods give the RRID and name the linePubMed
Biophysical reprogramming of immunosuppressive neutrophils by cold atmospheric plasma reinvigorates antitumor immunity.Sci Adv2026Its Methods give the RRID and name the linePubMed
The YTHDC1/HECW1/SMAD7 axis drives cisplatin resistance in bladder cancer.Transl Androl Urol2026Its Methods give the RRID and name the linePubMed
The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function.Pharmacol Res Perspect2026Its Methods give the RRID and name the linePubMed
O-GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
HSPB6: A Potential Prognostic Biomarker, Inhibiting the Epithelial-Mesenchymal Transition (EMT) Process Through the PI3K/Akt Signaling Pathway Based on the Machine Learning and Experimental Validation.
Hum Mutat2026Its Methods give the RRID and name the linePubMed
The Physicochemical Synergy Effect of Nanosecond Pulsed Electric Fields (nsPEF) and cisplatin on reversing chemoresistance of bladder cancer.PLoS One2026Its Methods give the RRID and name the linePubMed
Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy.Cancer Res2026Its Methods give the RRID and name the linePubMed
Targeting TPX2-dependent lineage plasticity by CDK4/6 inhibition reverses therapy resistance in neuroendocrine bladder carcinoma.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
The bladder cancer m6A landscape is defined by global methylation dilution and focal 3'-UTR hypermethylation.EMBO Rep2026Its Methods give the RRID and name the linePubMed
A 'two-in-one' tumor-specific-hydrogel-assisted strategy for intravesical chemotherapy and protection of normal tissues.J Nanobiotechnology2026Its Methods give the RRID and name the linePubMed
m5C-Modified tRF3b-CysGCA-23 Suppresses Bladder Cancer Malignancy by Repressing H3K18 Lactylation via Stabilizing RBM4.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
FomA-Containing Outer Membrane Vesicles of Fusobacterium Nucleatum Facilitate Bladder Cancer Lymphatic Metastasis via IL-6-Dependent M2b Macrophage Polarization.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
TENT5A Maintains MYC mRNA Stability to Enhance Osteosarcoma Stemness.Cancer Res2026Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0554/papers

API referenceFor AI assistants